CoChat

Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin‐bound iron in dialysis patients

Espósito, B. P., Breuer, W., Slotki, I., Cabantchik, Z. I. · 2002 · European Journal of Clinical Investigation
Cited by 115

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background Labile plasma iron (LPI) associated with iron supplementation has been implicated in complications found in dialysis patients. As LPI can potentially catalyse oxygen radical generation, we determined the presence of labile iron in the parenteral preparations and the frequency of occurrence of LPI in dialysis patients. Design The capacity to donate iron to apotransferrin (apo‐) or to the chelator desferrioxamine (DFO) was measured with fluorescein‐Tf (Fl‐Tf) and Fl‐DFO, respectively. Those probes undergo quenching upon binding to iron. Iron‐catalysed generation of oxidant species was determined with dihydrorhodamine. Plasma nontransferrin‐bound iron (NTBI), here termed LPI, was determined by mobilization of iron from low‐affinity binding sites with oxalate, followed by its quantification with Fl‐Tf in the presence of Ga(III). Results Normal individuals and most (80%) dialysis patients, analysed at least 1 week after iron supplementation showed no detectable (<0·2 µ m) LPI. However, ≈20% of the patients (n = 71) showed significant LPI levels (>0·2 µ m), in some cases weeks after iron administration. LPI levels correlated best (r2 = 0·9) with Tf saturation. The iron preparations contained 2–6% low molecular weight and redox‐active iron, most of which is chelated by Tf. Conclusions Parenteral iron formulations contain a small but significant fraction of redox‐active iron, most of which is scavenged by apo‐Tf within <1 h. Therefore, oxidant stress associated with iron infusion is likely to be transient. The bulk of the polymeric iron is apparently inaccessible to apo‐Tf. Although LPI might return to normal within 2 h of intravenous iron infusion, the long‐term persistence of low‐level LPI in up to 20% of end stage renal disease (ESRD) patients indicates that complete clearance of the intravenous iron may be more protracted than originally estimated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2362.2002.0320s1042.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 115

Metadata

Authors
Espósito, B. P., Breuer, W., Slotki, I., & Cabantchik, Z. I.
Venue
European Journal of Clinical Investigation
Publisher
Wiley
Published
2002-03
Volume
32
Issue
s1
Pages
42-49
ISSN
  • 0014-2972 (ISSN-L)
  • 1365-2362
OpenAlex
W2147825080
Cited by
115
References
5
FWCI
4.48
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin‐bound iron in dialysis patients. https://app.cochat.ai/papers/10.1046/j.1365-2362.2002.0320s1042.x
The paper
Espósito, B. P., Breuer, W., Slotki, I., & Cabantchik, Z. I. (2002). Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin‐bound iron in dialysis patients. European Journal of Clinical Investigation. https://doi.org/10.1046/j.1365-2362.2002.0320s1042.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.